Second national sero-survey to be completed in September first week: ICMR

Video Credit: ANI
Published on August 25, 2020 - Duration: 01:49s

Second national sero-survey to be completed in September first week: ICMR

Indian Council of Medical Research, Director General Dr. Balram Bhargava during Health Ministry's briefing on COVID-19 situation in India informed about the sero survey publication.

Bhargava said, "ICMR sero survey is publication in-progress.

It should appear by this week in the Indian Journal of Medical Research.

It has been peer reviewed.

The second national sero-survey should be completed in the first week September".

On situation of COVID-19 vaccines in India, Balram Bhargava said, "Three COVID-19 vaccines are ahead in the race in India.

Serum Institute's vaccine is in phase 2(B) and phase 3 trials and Bharat Biotech and Zydus Cadila's vaccines have completed phase 1 trial."


You are here


๐Ÿ’ก newsR Knowledge: Other News Mentions


The paper-strip uses cutting-edge CRISPR gene-editing technology to identify and target the genetic material of SARS-CoV-2, the virus that causes Covid-19 in..
Credit: IndiaTimes - Published 1 day ago

The Bharatiya Janata Party (BJP) on Thursday released its manifesto for three-phased Bihar elections and promised that after approval of coronavirus vaccine from..
Credit: DNA - Published 1 day ago

Credit: IndiaTimes - Published 1 day ago

The Indian Council of Medical Research (ICMR) on Thursday issued an advisory on the CRISPR SARS CoV-2 test that has been approved by the Drugs Controller General..
Credit: IndiaTimes - Published 1 day ago

Credit: IndiaTimes - Published 2 days ago


All such travellers will however have to strictly adhere to the guidelines of the Ministry of Health and Family Welfare regarding quarantine and other..
Credit: DNA - Published 2 days ago

Active cases of Covid-19 in India have fallen below 10 per cent while the positivity rate of the disease was reported below 5 per cent in the last three days,..
Credit: IndiaTimes - Published 2 days ago

With a spike of 55,838 new Covid-19 cases and 702 deaths in the last 24 hours, India's Covid-19 count crossed 77-lakh mark and reached 77,06,946 on Thursday,..
Credit: IndiaTimes - Published 3 days ago

With a spike of 54,044 new Covid-19 cases and 717 deaths in the last 24 hours, India's Covid-19 count crossed the 76-lakh mark and reached 76,51,108 on..
Credit: IndiaTimes - Published 3 days ago

As per the MoHFW, the Covid-19 count includes 7,40,090 active cases and 67,95,103 cured/discharged/migrated cases. With 717 deaths in the last 24 hours, the..
Credit: IndiaTimes - Published 3 days ago


Bharat Biotech

Indian biotechnology company and vaccine manufacturer
Besides, Bharat Biotech, Zydus Cadila Ltd is also in Phase 2 of human clinical trials of a COVID-19 vaccine.
Credit: DNA - Published 6 hours ago

Credit: IndiaTimes - Published 1 day ago

The recommendation was given by the panel after assessing the data of phase 1 and 2 clinical trials as well as animal challenge study.
Credit: DNA - Published 2 days ago


Related videos from verified sources

Explained | 70% Delhi residents vulnerable to Covid, as per 2nd sero survey 03:09
Video credit: HT Digital Content - Published on August 20, 2020 

Covid | 'Oxford vaccine's late stage trials to start in a week in India': ICMR 06:42
Video credit: HT Digital Content - Published on August 4, 2020 

Covid update: Russia mass vaccination from Oct plan; Delhi 2nd sero survey 03:09
Video credit: HT Digital Content - Published on August 1, 2020 

You might like